The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2024Quantification of Three Previously Identified Biomarkers of Progression in Stage 2/3 of Parkinson’s Disease
Study Rationale: Early indicators for Parkinson’s disease (PD), so-called biomarkers, are needed to identify subjects at risk during the earliest, prodromal stages of disease and to support clinical...
-
Research Grant, 2024Funding Support 2024-2026 for Critical Path Clinical Outcome Assessment Experts
Study Rationale: To evaluate treatments in ways that are meaningful to people with Parkinson’s disease (PD), we need to identify measurements that reflect how people with early PD function and feel...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024Investigating Oxygen Limitation (Hypoxia) as a Novel Treatment for Parkinson’s Disease
Study Rationale: Non-pharmacological interventions can benefit human health, and anecdotal evidence suggest that people with Parkinson’s disease (PD) show fewer symptoms when traveling at high...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biology, 2024Enhancing Removal of Damaged Mitochondria in Neurons by Inhibiting the Enzyme Usp8
Study Rationale: Parkinson’s disease (PD) has long been associated with mitochondrial dysfunction. Perturbation of these subcellular structures can lead to the release of reactive oxygen species (ROS)...
-
Research Grant, 2024Planning for a Dynamic Microsimulation Model of the Health and Financial Effects of Parkinson’s Disease
Study Rationale: As new treatments for Parkinson's disease (PD) are developed, it is important to determine how they might affect the health and finances of people with PD, their families and society...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biomarkers, 2024Development and Validation of a Sensitive Method for Measuring PRKN
Study Rationale: Mutations in the genes encoding PRKN and PINK1 are associated with Parkinson’s disease (PD). PINK1 and PPKN proteins work together to mediate the degradation of damaged mitochondria...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.